Effects and pharmacokinetics of high dose metoprolol on chest pain in patients with suspected or definite acute myocardial infarction

European Journal of Clinical Pharmacology

Volumn 53, Issue 1, 1997, Pages 23-31

  Everts, B ^a   Karlson, B W ^b   Herlitz, J ^a   Abdon, N J ^b   Hedner, T ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UDDEVALLA HOSPITAL   (Sweden)

Author keywords

hydroxymetoprolol; Analgesia; Chest pain; Metoprolol; Myocardial infarction

Indexed keywords

ADRENALIN; METOPROLOL; NEUROPEPTIDE Y; NORADRENALIN;

ACUTE HEART INFARCTION; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG TOLERABILITY; ELECTROCARDIOGRAM; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; THORAX PAIN;

AGED; AGED, 80 AND OVER; ANALGESIA; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CATECHOLAMINES; CHEST PAIN; FEMALE; HEART RATE; HUMANS; MALE; METOPROLOL; MIDDLE AGED; MYOCARDIAL INFARCTION; PAIN MEASUREMENT; RESPIRATION;

EID: 0030959774     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050332     Document Type: Article

References (36)

1. Herlitz J, Hjalmarson Å, Waagstein F (1989) Treatment of pain in acute myocardial infarction. Br Heart J 61: 9-13
2. Petch MC (1989) Myocardial infarction. In: Julian DG, Camm AJ, Fox KM, Hall RJC, Poole-Wilson PA (eds) Diseases of the heart. Baillière, Tindall, London, pp 1157-1191
3. Herlitz J, Hjalmarson Å, Holmberg S, Pennert K, Swedberg K, Vedin A, Waagstein F, Waldenström A, Wedel H, Wilhelmsen L, Wilhelmsson C (1984) Effect of metoprolol on chest pain in acute myocardial infarction. Br Heart J 51: 438-444
4. Ramsdale DR, Faragher EB, Bennet DH, Bray CL, Ward C, Cruickshank JM, Yusuf S, Sleight P (1982) Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol. Am Heart J 103:459-67
5. The international collaborative study group (1984) Reduction of infarct size with the early use of timolol in acute myocardial infarction. N Engl J Med 310: 9-15
6. The MIAMI trial research group (1985) The MIAMI trial: narcotic analgesics and other antianginal drugs. Am J Cardiol 56: 30G-34G
7. Herlitz J, Elmfeldt D, Hjalmarson Å, Holmberg S, Malek I, Nyberg G, Rydén L, Swedberg K, Vedin A, Waagstein F, Waldenström A, Waldenström J, Wedel H, Wilhelmsen L, Wilhelmsson C (1983) Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarction. Am J Cardiol 51: 1282-1288
8. The MIAMI trial research group (1985) The MIAMI trial: enzymatic estimation of infarct size. Am J Cardiol 56: 27G-29G
9. Rydén L, Ariniego R, Arnman K, Herlitz J, Hjalmarson Å, Holmberg S, Reyes C, Smedgård P, Svedberg K, Vedin A, Waagstein F, Waldenström A, Wilhelmsson C, Wedel H, Yamamoto M (1983) A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med 308: 614-618
10. Norris RM, Brown MA, Clarke ED, Barnaby PF, Geary GG, Logan RL, Sharpe DN (1984) Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet ii: 883-886
11. ISIS-1 (First International Study of Infarct Survival) collaborative group (1986) Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 2: 57-65
12. The MIAMI trial research group (1985) Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. Eur Heart J 6:199-226
13. Hjalmarson Å, Elmfeldt D, Herlitz J, Holmberg S, Malek I, Nyberg G, Rydén L, Swedberg K, Vedin A, Waagstein F, Waldenström A, Waldenström J, Wedel H, Wilhelmsen L (1981) Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet ii: 823-827
14. The Norwegian Multicenter Study Group (1981) Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304: 801-807
15. Myers M, Thiessen JJ (1980) Metoprolol kinetics and dose response in hypertensive patients. Clin Pharm Ther 27: 756-762
16. Nattel S, Gagne G, Pineau M (1987) The pharmacokinetics of lignocaine and β-adrenoceptor antagonists in patients with acute myocardial infarction. Clin Pharmacokinet 13:293-316
17. Lennard MS, Silas JH, Freestone S, Ramsey LE, Tucker GT, Woods HF (1982) Oxidation phenotype - a major determinant of metoprolol metabolism and response. N Engl J Med 307: 1558-1560
18. Ervik M, Hoffman K, Kylberg-Hanssen K (1981) Selected ion monitoring of metoprolol and two metabolites in plasma and urine using deuterated internal standards. Biomed Mass Spectrom 8: 322-326
19. Regårdh CG, Jordö L, Ervik M, Lundborg P, Olsson R, Rönn O (1981) Pharmacokinetics of metoprolol in patients with hepatic cirrhosis. Clin Pharmacokinet 6: 375-388
20. Laurence DR, Bennett PN (1992) Clinical pharmacology. Churchill Livingstone, Edinburgh, pp 1-686
21. Hjemdahl P, Daleskog M, Kahan T (1976) Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci 25: 131-138
22. Hirsh JM, Hedner J, Wernstedt L, Lundberg JM, Hedner T (1992) Hemodynamic effects of the use of oral snuff. Clin Pharmacol Ther 52: 394-401
23. Feng QP, Hedner T, Andersson L, Lundberg JM, Waagstein F (1994) Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure. Br Heart J 71: 261-267
24. Bondestam E, Hovgren K, Gaston Johansson F, Jern S, Herlitz J, Holmberg S (1987) Pain assessments by patients and nurses in the early phase of acute myocardial infarction. J Advanced Nursing 12: 677-682
25. Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker, New York, pp 33-40
26. Haeusler G (1990) Pharmacology of β-blockers: classical aspects and recent developments. J Cardiovasc Phannacol 16 [Suppl 5]: S1-S9
27. Åblad B, Abrahamsson T, Adler G, Björknian JA, Bjurö T, Ek L, Ervik M, Sjöquist PO, Sutherland I, Svensson L (1987) Cardiac antiischemic effect of metoprolol: role of β-blockade within the ischemic region. J Cardiovasc Pharmacol 10 [Suppl 2]: 17-125
28. Rydén L, Tadokoro H, Sjöqvist PO, Kar S, Ervik M, Corday E (1990) Pronounced accumulation of metoprolol in ischemic myocardium after coronary venous retroinfusion. J Cardiovasc Pharmacol 15: 22-28
29. Held P, Regårdh CG (1986) Metoprolol in acute myocardial infarction. A pharmacokinetic and pharmacodynamic study. Eur J Clin Pharmacol 31: 261-265
30. Sannerstedt R, Wasir H (1977) Acute haemodynamic effects of metoprolol in hypertensive patients. Br J Clin Pharmacol 4: 23-26
31. Ritchie R, Wuttke R, Stafford I, Horowitz J (1994) Relation between acute myocardial uptake and hemodynamic and electrocardiographic effects of metoprolol in humans. J Cardiovasc Pharmacol 23: 57-65
32. Herlitz J, Hjalmarson Å, Swedberg K, Vedin A, Waagstein F, Waldenström A, Wilhelmsson C (1986) The influence of early intervention in acute myocardial infarction on long-term mortality and morbidity as assesed in the Göteborg metoprolol trial. Int J Cardiol 10: 291-301
33. Waagstein F, Hjalmarsson Å (1976) Double-blind study of the effect of cardioselective beta-blockade on chest pain in acute myocardial infarction. Acta Med Scand 587: 201-208
34. Gold HK, Leinbach RC, Maroko PR (1976) Propranolol-induced reduction of signs of ischemic injury during acute myocardial infarction. Am J Cardiol 38: 689-695
35. Risenfors M, Herlitz J, Bergh CH, Dellborg M, Gustavsson G, Gottfridsson C, Lomsky M, Swedberg K, Hjalmarson Å (1991) Early treatment with thrombolysis and beta-blockade in suspected acute myocardial infarction: results from the TEAHAT Study. J Intern Med 229 [Suppl 1]: 35-42
36. Herlitz J, Hartford M, Aune S, Karlsson T (1993) Occurrence of hypotension during streptokinase infusion in suspected acute myocardial infarction, and its relation to prognosis and metoprolol therapy. Am J Cardiol 71: 1021-1024